Shanghai Pharmaceuticals (2607 HK) - Recent surge in share price makes us wary - Avoid the deal

368 Views12 Mar 2015 19:15
Temasek plans to sell US$80m dollars worth of Shanghai Pharmaceutical shares, or about half of its current holding. We would avoid the deal...
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Sumeet Singh
Head of Research, IPOs & Placements
Aequitas Research
EquitiesEquity Capital Markets
Price Chart(Sign Up to Access)
analytics-chart
  • Shanghai Pharmaceuticals (2607 HK) - Recent surge in share price makes us wary - Avoid the deal
    12 Mar 2015
x